Trevi Therapeutics Inc.

4.26
-0.26 (-5.75%)
At close: Mar 03, 2025, 3:59 PM
4.35
2.11%
After-hours: Mar 03, 2025, 07:29 PM EST

Trevi Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 123K 43K 50K 47K 39K 23K n/a 4K
Gross Profit -123K -43K -50K -47K -39K -23K n/a -4K
Operating Income -33.92M -29.91M -32.48M -32.49M -26.64M -18.41M -8.24M -8.63M
Interest Income 4.75M 1.74M 10K 178K 792K 156K 69K 2.61M
Pretax Income -29.1M -29.19M -33.96M -32.78M -26.07M -20.67M -12.89M -11.1M
Net Income -29.07M -29.15M -33.94M -32.76M -26.05M -20.55M -12.86M -11.09M
Selling & General & Admin 10.24M 10.07M 9.49M 10.16M 7.31M 4.34M 2.14M 1.71M
Research & Development 23.68M 19.83M 22.98M 22.33M 19.34M 14.07M 6.09M 6.91M
Other Expenses n/a 719K -375K -287K 577K -2.24M -24K n/a
Operating Expenses 33.92M 29.91M 32.48M 32.49M 26.64M 18.41M 8.24M 8.62M
Interest Expense 391K 780K 1.2M 456K n/a 174K 3.34M n/a
Selling & Marketing Expenses 287K n/a n/a n/a n/a n/a n/a 50K
Cost & Expenses 33.92M 29.91M 32.48M 32.49M 26.64M 18.41M 8.24M 8.63M
Income Tax -32K -36K -21K -18K -18K -124K -26K -8K
Shares Outstanding (Basic) 99.03M 64.54M 22.84M 18.06M 11.74M 8.97M 8.97M 16.14M
Shares Outstanding (Diluted) 99.03M 64.54M 22.84M 18.06M 11.74M 8.97M 8.97M 16.14M
EPS (Basic) -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -0.69
EPS (Diluted) -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -0.69
EBITDA -33.8M -29.86M -32.43M -32.44M -26.61M -18.39M -8.19M -8.62M
Depreciation & Amortization 123K 43K 50K 47K 39K 23K 4K 4K